← Back to Analyst Consensus 
GNRC Buy
GENERAC HOLDINGS INC.
Current Price —
Implied Upside —
Analysts 28
30-Day Momentum
▲ 2 upgrades / ▼ 0 downgrades / 4 reiterations from 5 firms
Next Earnings
Oct 28, 2026 (2 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Oct 8, 2026 | Piper Sandler | initiate | — → Overweight | — | 54% |
| Oct 8, 2026 | Keybanc | upgrade | Sector Weight → Overweight | — | 53% |
| Oct 5, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Sep 30, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Sep 30, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Sep 18, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Sep 17, 2026 | Roth Capital | maintain | Neutral → Neutral | — | 53% |
| Sep 17, 2026 | Stephens & Co. | reiterate | Overweight → Overweight | — | 54% |
| Sep 17, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Sep 17, 2026 | Cantor Fitzgerald | reiterate | Overweight → Overweight | — | 50% |
| Sep 17, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Aug 4, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jul 30, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 30, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Jul 30, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 30, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jul 22, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Jul 2, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Jun 30, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jun 11, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 22, 2026 | Jefferies | upgrade | Hold → Buy | — | 52% |
| May 21, 2026 | Stephens & Co. | reiterate | Overweight → Overweight | — | 54% |
| May 5, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 5, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| May 1, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Apr 30, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Apr 30, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Apr 30, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 30, 2026 | Argus Research | maintain | Buy → Buy | — | 53% |
| Apr 21, 2026 | Citigroup | maintain | Neutral → Neutral | — | 54% |
| Apr 1, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Mar 27, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Mar 26, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| Mar 26, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Mar 26, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Mar 12, 2026 | Citigroup | downgrade | Buy → Neutral | — | 54% |
| Feb 13, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | $213 | 53% |
| Feb 12, 2026 | Guggenheim | downgrade | Buy → Neutral | $0 | 52% |
| Feb 12, 2026 | Wells Fargo | maintain | Overweight → Overweight | $234 | 54% |
| Feb 10, 2026 | Guggenheim | reiterate | Buy → Buy | $202 | 52% |
| Jan 20, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | $186 | 53% |
| Jan 13, 2026 | Canaccord Genuity | maintain | Buy → Buy | $236 | 48% |
| Jan 12, 2026 | Needham | initiate | — → Buy | $211 | 50% |
| Jan 9, 2026 | Baird | upgrade | Neutral → Outperform | $199 | 55% |
| Jan 8, 2026 | Citigroup | upgrade | Neutral → Buy | $207 | 54% |
| Jan 7, 2026 | B of A Securities | maintain | Buy → Buy | $224 | 53% |
| Dec 19, 2025 | Wells Fargo | upgrade | Equal-Weight → Overweight | $195 | 54% |
| Dec 8, 2025 | JP Morgan | upgrade | Neutral → Overweight | $200 | 54% |
Price Target Trend
Jun 13, 2026 Latest: $286.44 Oct 25, 2026
EPS Estimates
0q $2.43
Lo: $2.21 Hi: $2.88
17 analysts ▲1
+1y $12.97
Lo: $11.31 Hi: $16.03
19 analysts ▲4
0y $9.71
Lo: $9.26 Hi: $10.22
18 analysts +1q $2.53
Lo: $1.83 Hi: $2.83
17 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days